Applicability of the FISH test for bladder cancer.
نویسندگان
چکیده
Fluorescence in situ hybridization (FISH) analysis is an FDA-approved, urine-based marker that assists in diagnosis and surveillance of invasive urothelial cancer. This article provides an overview and case study demonstrating the clinical use of this analysis. As a systematic review of non-randomized and randomized clinical trials, this article provides Level I evidence.
منابع مشابه
سطح سرمی عناصر کمیاب آهن، مس و روی در بیماران مبتلا به سرطان مثانه در مقایسه با افراد سالم
Abstract Background: Despite the high prevalence and recurrence of bladder cancer, researches about the role of trace elements such as iron, copper and zinc in bladder cancer are limited in number. In the present study the concentration of Iron, Copper and Zinc, (Fe, Cu and Zn) were determined in the serum of patients with bladder cancer and compared with the level of these trace elements ...
متن کاملAge distribution types of bladder cancers and their relationship with opium consumption and smoking
Background: Recognition of the predisposing factors of bladder cancer is very important and provides possible prevention measures. The aim of this study was to investigate the types, distribution of bladder tumors and their relationship with opium consumption and smoking in patients who referred to Shahid Beheshti Hospital, Babol, Iran. Methods: In this case-control study, all patients ...
متن کاملMicroRNAs as biomarkers associated with bladder cancer
Bladder cancer is the fifth most common cancer with significant morbidity and mortality. Recently, numerous studies demonstrated that microRNAs are emerging as diagnostic biomarkers for bladder cancer. Specific miRNA profiles have been identified for several samples from patients with bladder cancer. MicroRNAs are noncoding RNA molecules of approximately 23 nucleotides that play important roles...
متن کاملFluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette–Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer
A significant number of patients with intermediate- or high-risk bladder cancer treated with intravesical Bacillus Calmette-Guérin (BCG) immunotherapy are non-responders to this treatment. Since we cannot predict in which patients BCG therapy will fail, markers for responders are needed. UroVysion® is a multitarget fluorescence in situ hybridization (FISH) test for bladder cancer detection. The...
متن کاملA review of biomarkers in the diagnosis of bladder cancer
Bladder cancer is among the ten most common cancers and the ten main causes of cancer-related deaths in the world. Currently, bladder tumors are diagnosed and followed up using a combination of cystoscopy and cytology. In addition, bladder cancer often recurs and can progress if not closely monitored after initial treatment. Constant monitoring of the patient with cystoscopy, which is an invasi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Urologic nursing
دوره 30 4 شماره
صفحات -
تاریخ انتشار 2010